During the past decade, J&S Studies, Inc. conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 29 clinical trials were completed, i.e. on average, 85.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 14 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "J&S Studies, Inc." #1 sponsor was "Galderma R&D" with 12 trials, followed by "Pfizer" with 5 trials sponsored, "Allergan" with 4 trials sponsored, "Botanix Pharmaceuticals" with 4 trials sponsored and "Peplin" with 4 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "J&S Studies, Inc." #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Athenex, Inc." with 2 trials as a collaborator, "Therapeutics, Inc." with 2 trials as a collaborator, "Bioskin GmbH" with 1 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "J&S Studies, Inc." are "Acne Vulgaris" (20 trials), "Onychomycosis" (7 trials), "Actinic Keratosis" (6 trials), "Atopic Dermatitis" (6 trials) and "Rosacea" (5 trials). Many other conditions were trialed in "J&S Studies, Inc." in a lesser frequency.

Most popular intervention types in "J&S Studies, Inc." are "Drug" (90 trials), "Other" (6 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vehicle" (15 trials), "Placebo" (12 trials), "AN2690" (3 trials), "Aminolevulinic Acid (ALA)" (2 trials) and "NAFT-500" (2 trials). Other intervention names were less common.

The vast majority of trials in "J&S Studies, Inc." are 86 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "J&S Studies, Inc.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 84 completed trials in J&S Studies, Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in J&S Studies, Inc., 13 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".